22nd Jun 2023 13:38
Poolbeg Pharma PLC - London-based infectious disease focused biopharmaceutical company - Says oral vaccine programme is moving forward to encapsulation validation process. Expects validation to be completed in the second half of 2023. Back in November, Poolbeg's consortium EncOvac received funding of EUR2.3 million from the Irish government to improve the manufacturing, distribution and administration of its oral vaccines. Poolbeg is collaborating with University College Dublin, Trinity College Dublin and AnaBio Technologies over three years to develop an oral vaccine candidate to a phase 1 ready state. Read More
